Amedisys, Inc. (AMED) Posts Q3 EPS of 6c; Trims FY13 Outlook
Tweet Send to a Friend
Amedisys, Inc. (NASDAQ: AMED) reported Q3 EPS of $0.06, $0.07 worse than the analyst estimate of $0.13. Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
